Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGRP
3026
DELISTED
SPAR Group
SGRP
| $63.6K | ﹤0.01% |
76,941
-48,367
| -39% | -$33.4K |
|
3027
Smith Micro Software
SMSI
$15.9M
| $63.3K | ﹤0.01% |
23,625
+296
| +1% | +$1.1K |
|
|
FBGL
3028
FBS Global
FBGL
$5.33M
| $62.9K | ﹤0.01% |
123,292
-21,200
| -15% | -$12.3K |
|
3029
Beamr Imaging
BMR
$20.2M
| $62.7K | ﹤0.01% |
44,800
-200
| -0.4% | -$350 |
|
3030
Tandy Leather Factory
TLF
$21.6M
| $62.7K | ﹤0.01% |
26,912
+10,212
| +61% | +$24K |
|
3031
Aligos Therapeutics
ALGS
$36M
| $62.3K | ﹤0.01% |
10,800
-89,650
| -89% | -$554K |
|
|
AIFA
3032
All In FutureTech Alliance Inc
AIFA
$19.5M
| $61.2K | ﹤0.01% |
27,453
+6,221
| +29% | +$16.6K |
|
3033
Roadzen
RDZN
$110M
| $60.5K | ﹤0.01% |
+41,441
| New | +$65.8K |
|
|
AACG
3034
ATA Creativity
AACG
$41M
| $60.2K | ﹤0.01% |
58,444
-2,200
| -4% | -$2.4K |
|
3035
Hydrofarm Holdings
HYFM
$4.46M
| $59.8K | ﹤0.01% |
70,363
-1,800
| -2% | -$1.76K |
|
3036
Mind CTI
MNDO
$20.2M
| $59.7K | ﹤0.01% |
57,952
+35,478
| +158% | +$35.7K |
|
|
ONCY
3037
Oncolytics Biotech
ONCY
$103M
| $58.9K | ﹤0.01% |
62,010
-653,828
| -91% | -$606K |
|
3038
Moving iMage Technologies
MITQ
$5.96M
| $58.8K | ﹤0.01% |
101,400
-21,000
| -17% | -$12.6K |
|
3039
Claros Mortgage Trust
CMTG
$217M
| $58K | ﹤0.01% |
24,700
-24,100
| -49% | -$59.1K |
|
3040
Bionano Genomics
BNGO
$14.1M
| $57.7K | ﹤0.01% |
51,100
+2,400
| +5% | +$2.89K |
|
3041
Dolphin Entertainment
DLPN
$15.2M
| $56.9K | ﹤0.01% |
49,500
-25,500
| -34% | -$33.6K |
|
|
NYXH
3042
Nyxoah
NYXH
$159M
| $56.6K | ﹤0.01% |
+33,480
| New | +$88.3K |
|
|
YI
3043
111 Inc
YI
$28.2M
| $56K | ﹤0.01% |
12,914
-100
| -0.8% | -$563 |
|
|
XXI
3044
Twenty One Capital Inc
XXI
$3.3B
| $54.9K | ﹤0.01% |
+11,100
| New | +$77.9K |
|
|
YDDL
3045
One and One Green Technologies
YDDL
$93.6M
| $53.7K | ﹤0.01% |
+26,600
| New | +$125K |
|
3046
MicroCloud Hologram
HOLO
$39.2M
| $53.3K | ﹤0.01% |
+34,621
| New | +$63.7K |
|
3047
Myomo
MYO
$53.1M
| $50.4K | ﹤0.01% |
48,500
+24,900
| +106% | +$24.3K |
|
3048
Sonoma Pharmaceuticals
SNOA
$6.37M
| $49.8K | ﹤0.01% |
+40,468
| New | +$57.8K |
|
3049
INmune Bio
INMB
$69.7M
| $48.4K | ﹤0.01% |
29,700
+12,700
| +75% | +$17.6K |
|
|
BLRX
3050
BioLineRX
BLRX
$12.6M
| $48.1K | ﹤0.01% |
+15,412
| New | +$44.7K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.